We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » President’s Panel Calls for Value-Based Pricing, Increased Competition to Lower Cancer Drug Prices
President’s Panel Calls for Value-Based Pricing, Increased Competition to Lower Cancer Drug Prices
The President’s Cancer Panel highlighted the sharp increase in U.S. cancer drug prices in a 70-page report to President Trump, calling for more value-based pricing, more competition in the drug market and “meaningful communication” about treatment options.